L-Glutamine

L-Glutamine

L-Glutamine is the most abundant amino acid in your body and the primary fuel for the cells lining your gut. Most people take it for one of two reasons: to settle a gut that's been through something (chronic stress, an infection, antibiotics, IBS-style symptoms, heavy training, or anything that's left them feeling bloated, irregular, or generally inflamed) or to support recovery and immunity when training load is high enough to deplete them.
Unlike most supplements, glutamine has a clear-cut FDA-approved use, reducing pain crises in sickle cell disease, which gives us solid safety data on doses up to 30g/day in long-term use. For everyone else, it sits in a more nuanced space: genuinely useful when there's an actual deficit to fill (damaged gut lining, post-infectious IBS, intense catabolic stress), and largely redundant when there isn't. Your body makes 50-80g of it daily and you eat another 3-10g from protein, so under normal conditions, supplementation does very little. Under load, it's one of the few amino acids that becomes conditionally essential.

Deep-dive

Glutamine is classified as non-essential because your body synthesises it from glutamate and ammonia using glutamine synthetase, primarily in skeletal muscle, liver, and brain. Endogenous production runs roughly 50-80g per day, and dietary intake adds another 3-10g depending on how much protein you eat. The phrase "conditionally essential" matters here. Under normal conditions, your body makes plenty. Under sustained catabolic stress (sepsis, major trauma, burns, prolonged endurance exercise, post-surgical recovery), demand outstrips supply and plasma glutamine drops, which is why ICU and surgical nutrition protocols include it.
Gut barrier function. This is the strongest mechanistic story for glutamine. Enterocytes, the cells lining your small intestine, get roughly 30% of their energy from glutamine rather than glucose, making it their preferred fuel. Glutamine also upregulates the expression of tight junction proteins (claudin-1, occludin, ZO-1) that hold the intestinal barrier closed. When the barrier loosens (from infection, NSAIDs, alcohol, chronic stress, intense exercise, or chemotherapy), bacterial fragments and partially digested proteins can leak into circulation, driving systemic inflammation. The clinical evidence for restoring this barrier is mixed but pointed. A 2019 randomized trial in Gut tested 5g three times daily for 8 weeks in 106 patients with post-infectious IBS-D and found 79.6% in the glutamine group hit the symptom response endpoint compared to 5.8% on placebo, a 14-fold difference, alongside normalization of intestinal permeability. A 2021 trial combining glutamine with low-FODMAP showed 15g/day for 6 weeks added meaningful symptom reduction beyond diet alone. A 2024 meta-analysis of clinical trials found no overall effect on intestinal permeability, but a significant reduction at doses above 30g/day, suggesting the dose threshold matters more than people often realize.
Immune function. Lymphocytes, macrophages, and neutrophils all use glutamine at high rates, particularly when activated. A 2018 review in Nutrients details how glutamine is essential for lymphocyte proliferation, cytokine production, macrophage phagocytic activity, and neutrophil bacterial killing. During catabolic stress, plasma glutamine falls and immune cell function follows. Systematic reviews of parenteral glutamine in critical illness show trends toward reduced infection and mortality, though high-dose IV glutamine in unstable septic patients with multi-organ failure has shown harm and isn't recommended. The translation to healthy people supplementing orally is weaker. Most studies in athletes have failed to show a meaningful reduction in upper respiratory infections from supplementation, probably because plasma glutamine in trained healthy adults doesn't drop low enough to limit immune function.
Muscle recovery and exercise. The picture here is more modest than supplement marketing suggests. A 2015 study found 0.3 g/kg of glutamine taken at 0, 24, 48, and 72 hours after 100 drop jumps significantly attenuated strength loss and reduced perceived muscle soreness compared to placebo. Several other small trials have shown similar effects on perceived recovery. But glutamine doesn't appear to add much to muscle protein synthesis in healthy people on adequate protein, and it doesn't meaningfully improve performance, hypertrophy, or strength gains over time. The eccentric recovery effect is real but situational, useful around very damaging sessions, less relevant for normal training. Higher-dose intakes during heat stress (0.9 g/kg fat-free mass) are tolerable but not clearly better than moderate doses.
Sickle cell disease. This is the only FDA-approved indication. The phase 3 trial in NEJM randomized 230 patients with sickle cell anemia or sickle β0-thalassemia to oral L-glutamine (0.3 g/kg twice daily) or placebo for 48 weeks. The glutamine group had a lower median number of pain crises and fewer hospitalizations regardless of whether they were on hydroxyurea. The mechanism is thought to involve replenishing NAD+ and reducing oxidative damage to red blood cells. The drug is sold as Endari and dosed by weight: 5g twice daily under 30kg, 10g twice daily up to 65kg, and 15g twice daily above that.
Antioxidant and glutathione synthesis. Glutamine is a precursor (via glutamate) to glutathione, the body's main intracellular antioxidant. Mechanistic work in T cells confirms that glutamine catabolism feeds de novo glutathione synthesis. Whether oral supplementation in healthy people meaningfully raises tissue glutathione is less clear; cysteine availability is usually the rate-limiting step, not glutamine.
Women. Most exercise and gut studies have been done in men, but the few trials that included women show comparable effects. A 2021 trial in 44 elderly women (60-80 years) gave 0.3 g/kg/day for 30 days alongside resistance training and found significantly improved knee extensor torque, better glycemic control (lower fructosamine and insulin), and increased plasma glutathione compared to placebo. The IBS trials enrolled both sexes with similar response rates. Sex-specific dose adjustments aren't needed. One mechanistic note: animal work has shown sex-dependent effects of glutamine on gut microbiota and metabolic markers under high-fat diet conditions, with female mice showing different inflammatory responses, but this hasn't been translated to human clinical effects yet. Skip in pregnancy and breastfeeding, there isn't enough safety data, and dietary intake plus endogenous synthesis is already adequate.
Older adults. Endogenous glutamine synthesis can drop with age and muscle loss (skeletal muscle is a major synthesis site). The elderly women's trial above is the cleanest evidence that supplementation may meaningfully support strength and recovery in this group, particularly when combined with resistance training. Reasonable case for use in sarcopenic or recovering older adults.
Limitations of the evidence. Despite glutamine's popularity, the supplement-dose, healthy-person evidence base is thinner than people assume. Most strong data comes from clinical settings (ICU, surgical recovery, sickle cell, post-infectious IBS) where there's a real deficit to correct. In healthy, well-fed people, oral glutamine doesn't reliably raise plasma glutamine much because the gut absorbs and uses most of it on first pass, which is actually the point if your goal is gut barrier support, but limits how much reaches systemic circulation for other uses. The 2024 meta-analysis showing benefit only above 30g/day is a useful reality check on the typical 5g "scoop" dose.

Dosage:

  • Gut support (general): 5g, 1-3 times daily on an empty stomach, taken away from meals to maximize delivery to enterocytes. Start at 5g once daily and titrate up if well tolerated. This is the everyday dose for general gut barrier support, mild IBS-style symptoms, or recovery from a course of antibiotics.
  • Post-infectious IBS or significant gut barrier disruption: 5g three times daily (15g total) for 8 weeks, matching the protocol from the Zhou et al. trial. Reassess at 8 weeks, most of the effect lands in this window.
  • Heavy training / catabolic stress / endurance recovery: 0.3 g/kg body weight (roughly 20-25g for most people) split across the day, particularly post-session and before bed. Useful around very damaging eccentric sessions, fight camps, multi-day events, or periods of significant under-recovery. Not a daily must for normal training.
  • Sickle cell disease (FDA-approved): 0.3 g/kg twice daily, capped per the Endari label at 5g twice daily under 30kg, 10g twice daily for 30-65kg, and 15g twice daily above 65kg. This is a medical use and should be managed with a hematologist.
  • Older adults / sarcopenia: 0.3 g/kg/day alongside resistance training, based on the elderly women's trial. Reasonable case for support in recovering or sarcopenic older adults.
  • Timing: Take on an empty stomach where possible, especially for gut effects. With food is fine for systemic effects (recovery, immune support). Glutamine is heat-sensitive, don't add to hot drinks.
  • Form: Plain L-glutamine powder is the cheapest and works fine. The dipeptide form (L-alanyl-L-glutamine) is more stable in solution but for oral use the difference is marginal and the cost premium isn't justified. Avoid "glutamine peptides" of unspecified composition.
  • Duration: 4-8 week protocols for specific gut issues, with a break to assess. Long-term daily use above 5g isn't well-studied beyond the sickle cell population, so build in periodic breaks if you're using higher doses chronically.

Here's what you can expect:

If you're taking it for gut symptoms (bloating, irregular stools, post-infection or post-antibiotic discomfort, low-grade IBS-D), expect a gradual change over 2-6 weeks, not days. The clearest improvements show up in stool consistency, reduced bloating, and a vague sense that your gut feels less reactive. Some people notice nothing, particularly if their underlying issue isn't barrier-driven (food sensitivities, motility, overgrowth, structural issues all need different approaches).
If you're taking it for recovery from very damaging training, expect modestly less soreness 24-72 hours post-session and slightly faster strength return. It's noticeable but not dramatic. Don't expect changes in performance, hypertrophy, or anything that looks like a stimulant or anabolic effect, that's not what it does.
If you're well-fed, well-rested, training moderately, and your gut feels fine, you'll probably notice nothing. This is the most honest answer most people don't want to hear. Glutamine works to plug a deficit, not to push a healthy system above baseline.
For sickle cell patients, the trial endpoint was a reduction in median pain crises over 48 weeks, this is a long-term, statistical benefit, not something you feel day-to-day.

Side effects & risks:

  • Liver disease and ammonia. This is the one genuine hard contraindication. Glutamine metabolism produces ammonia, which a healthy liver clears easily. In cirrhosis or significant liver impairment, oral glutamine challenges (10-20g) raised venous ammonia and worsened subclinical hepatic encephalopathy. If you have any significant liver disease, don't take it.
  • Kidney disease. Glutamine is a major substrate for renal ammoniagenesis. People with significant renal impairment should avoid supplemental doses without medical oversight.
  • Long-term high-dose concerns. A 2013 review by Holecek raised theoretical concerns about chronic high-dose intake (40g+/day) altering amino acid transport, suppressing endogenous glutamine synthesis, and affecting ammonia handling. Most of the supporting evidence is from animal work and short-term human studies don't show these issues at moderate doses, but the case for chronic megadosing in healthy people is weak.
  • Cancer. Worth addressing because it comes up often. Tumor cells use glutamine avidly, which led to early concerns that supplementation might fuel growth. In vivo evidence in humans has not borne this out, and supplementation has been shown to be safe in patients undergoing chemotherapy and radiation, sometimes reducing treatment side effects. That said, if you have an active cancer diagnosis, this is a conversation to have with your oncologist, not a decision to make from a supplement page.
  • Drug interactions: Reduces the ammonia-lowering effect of lactulose. May interact with anticonvulsants by altering glutamate metabolism. Caution with chemotherapy regimens, discuss with your oncologist.
  • Pregnancy and breastfeeding: Skip it. Not because of documented harm, but because there isn't enough safety data and dietary intake covers requirements.
  • Rare hepatotoxicity. Idiosyncratic case reports describe acute liver injury (abdominal pain, jaundice) after weeks of high-dose powder use, with full recovery on discontinuation. Rare but possible.
🩸

Blood markers

Liver enzymes (ALT, AST) and ammonia, baseline before any chronic high-dose use, especially if you have a history of any liver issue, heavy alcohol use, or unexplained fatigue. Recheck at 3 months if running 15g+ daily.
Kidney function (creatinine, eGFR), baseline if using doses above 10g/day chronically, particularly in older adults or anyone with a history of kidney issues.
Comprehensive metabolic panel is sufficient for most people and covers both liver and kidney markers.
For most people taking 5g/day for gut support or short courses around training, no specific bloodwork is needed.
Sold as a dietary supplement in most countries without prescription. The pharmaceutical-grade form (Endari) is prescription-only in the US for sickle cell disease.